FDA recalls common heart drug due to cancer concerns

FDA recalls common heart drug due to cancer concerns

FDA recalls common heart drug due to cancer concerns

The U.S. Food and Drug Administration has announced a recall of several drugs that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure. There has been an impurity found in valsartan called N-nitrosodimethylamine (NDMA).

Officials say NDMA is a probable human carcinogen, or something that could cause cancer, and is believed to be related to how the products were manufactured.

According to the FDA, the presence of NDMA is these drugs was unexpected.

Sutherland on the launch pad to be Britain's first spaceport
Sutherland was in competition with other sites, including Prestwick in Ayrshire, Unst in Shetland and Newquay airport in Cornwall. The U.S. -based company has been a prominent member of the consortium supporting Sutherland's bid.


The recall doesn't include all products containing valsartan; valsartan medications made by Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd. are being recalled, along with valsartan/hydrochlorothiazide (HCTZ) from Solco Healthcare and Teva Pharmaceuticals Industries Ltd. "This is why we've asked these companies to take immediate action to protect patients", explained Janet Woodcock, director of FDA's Center for Drug Evaluation and Research. The DRAP Recall alert stated that a total of nine pharmaceutical companies in Pakistan are on the DRAP recall list and this list does not include Getz Pharma and its products: Cova, Covam and Cova-H.

To determine if a specific product has been recalled, look at the drug name and company name on the prescription bottle's label.

-Valsartan, manufactured by Teva Pharmaceuticals Industries Ltd.

Trump classe la Russie parmi les "ennemis" des États-Unis
Quant à Vladimir Poutine il était hier au stade Loujniki pour la finale de la coupe du monde de football organisée en Russie . Les Européens craignent que les Etats-Unis rompent avec la solidarité occidentale en se rapprochant de la Russie.


The FDA continues to review this situation and is investigating possible effects on patients taking these drugs and how companies can reduce or eliminate NDMA in future batches of medication.

Not all medications containing valsartan were included in FDA's recall.

More information will be posted on the FDA's website. The agency encourages patients and health care professionals to report any adverse reaction to the FDA's MedWatch program.

China files WTO challenge against latest USA tariff plan
Last week, the ministry said it would immediately file a complaint to the WTO against what it called U.S. unilateralism. Trump has also imposed tariffs on steel and aluminum imports on a host of trade partners including Canada and the EU.


Latest News